Since the first patient walked through its doors in 1944, The University of Texas MD Anderson Cancer Center has treated thousands of children in its quest to make cancer history. In 1955, MD Anderson Cancer Center opened an inpatient unit specifically dedicated for children with cancer. Since that time, the pediatric oncologists and specialists at MD Anderson have forged new paths in cancer therapy for children.
In 2005, our pediatric program was renamed the Children's Cancer Hospital at The University of Texas MD Anderson Cancer Center. The renaming marked the 50th anniversary of the pediatric program and aimed to send the message that children and cancer are a priority at MD Anderson.
The Children's Cancer Hospital is home to one of the largest multidisciplinary pediatric cancer care programs in the nation caring for approximately 1,700 children a year. Because our primary focus is cancer, we see more types of cancer than any other children's hospital in Houston or Texas.
Research Team
Dr. Herzog received her undergraduate degree in Biochemistry from Rice University in Houston, and MD for The University of Texas Medical Branch in Galveston. She completed a pediatric residency at Dallas Children’s Hospital and a fellowship in pediatric hematology and oncology at the National Cancer Institute. She is board certified in pediatric hematology/oncology. She joined the faculty at The University of Texas MD Anderson Cancer Center in 1992, where she currently serves as Deputy Division Head and Section Chief for Non-Neural Solid Tumors in the Division of Pediatrics. She has been a member of POETIC since its inception.
Dr. McCall received his dual undergraduate degree in psychology and criminal justice from Western Carolina in Cullowhee, North Carolina and MD degree from the Medical College of Georgia (MCG) in Augusta, GA. He completed a pediatric residency at The University of Alabama at Birmingham (UAB) and a fellowship in pediatric hematology and oncology at the University of Texas MD Anderson. He is board certified in pediatric hematology/oncology and pediatrics. He joined the faculty at The University of Texas MD Anderson Cancer Center in 2020, where he currently serves as head for clinical and non-therapeutic trials for hematological malignancies in the division of pediatrics. He has been a member of POETIC since 2020.